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Abstract
Background: Unsafe reuse of injection equipment in hospitals is an on-going threat to patient safety in many parts of
Africa. The extent of this problem is difficult to measure. Standard WHO injection safety assessment protocols used in the
2003 national injection safety assessment in Cameroon are problematic because health workers often behave differently
under the observation of visitors. The main objective of this study is to assess the extent of unsafe injection equipment
reuse and potential for blood-borne virus transmission in Cameroon. This can be done by probing for misconceptions
about injection safety that explain reuse without sterilization. These misconceptions concern useless precautions against
cross-contamination, i.e. “indirect reuse” of injection equipment. To investigate whether a shortage of supply explains
unsafe reuse, we compared our survey data against records of purchases.
Methods: All health workers at public hospitals in two health districts in the Northwest Province of Cameroon were
interviewed about their own injection practices. Injection equipment supply purchase records documented for January
to December 2009 were compared with self-reported rates of syringe reuse. The number of HIV, HBV and HCV
infections that result from unsafe medical injections in these health districts is estimated from the frequency of unsafe
reuse, the number of injections performed, the probability that reused injection equipment had just been used on an
infected patient, the size of the susceptible population, and the transmission efficiency of each virus in an injection.
Results: Injection equipment reuse occurs commonly in the Northwest Province of Cameroon, practiced by 44% of
health workers at public hospitals. Self-reported rates of syringe reuse only partly explained by records on injection
equipment supplied to these hospitals, showing a shortage of syringes where syringes are reused. Injection safety
interventions could prevent an estimated 14-336 HIV infections, 248-661 HBV infections and 7-114 HCV infections
each year in these health districts.
Conclusions: Injection safety assessments that probe for indirect reuse may be more effective than observational
assessments. The autodisable syringe may be an appropriate solution to injection safety problems in some
hospitals in Cameroon. Advocacy for injection safety interventions should be a public health priority.
Introduction
T h em o s tc o m m o ni n v a s i v eh e a l t hc a r ep r o c e d u r e si n
Cameroon are medical injections, which have the potential
to transmit blood-borne infections such as HIV, HBV and
HCV when injection equipment is unsafely reused [1,2].
Multiple use of single use devices is common practice due
to cost constraints in developing countries [3]. In Camer-
oon the cost of medical care is borne by a patient popula-
tion living in rural poverty-one third are below the
international poverty line of $1.25 per day [4]. Single use
d e v i c e ss u c ha sd i s p o s a b l es y r i n g e sa r en o td e s i g n e dt o
withstand heat sterilization for safe reuse. From a public
health perspective, unsafe reuse is not cost-saving [5]. The
costs of nosocomial infections resulting from unsafe reuse
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any medium, provided the original work is properly cited.are borne by the patients, who may face stigmatizing ill-
ness without knowing how they became infected.
S h o r t a g eo fs u p p l yi sn o tt h eo n l ye x p l a n a t i o nf o r
unsafe reuse. Many practices that endanger patient
safety are related to health workers’ misconceptions
about infection control. Probing for these misconcep-
tions may shed light on the prevalence of risky beha-
viors. Since 1992, more than 600 iatrogenic HBV and
HCV outbreaks have been traced to reuse of injection
equipment in countries with a low prevalence of these
viruses [6]. Important misconceptions identified behind
these outbreaks include the beliefs that (1) it is safe to
reuse a syringe after changing the needle, (2) it is safe to
reuse a needle or syringe on the same patient, re-entering
a multi-dose vial or saline bag with a used needle or syr-
inge, and (3) it is safe to reuse a needle or syringe when
accessing an IV port separated from the patient by inter-
vening lengths of IV tubing or the presence of heparin
locks or valves. In some instances providers change the
needle to reuse the syringe on the same patient only, but
the multidose vial may nevertheless become contami-
nated under these circumstances. These specific practices
are sometimes referred to as “indirect reuse,” as opposed
to overt reuse of needles and syringes without any of
these useless precautions.
An experimental assessment of two of these precau-
tions-changing the needle to reuse the syringe, and reus-
ing only to access an injection port separated from the
patient by a length of IV tubing protected by heparin
locks or valves-found neither precaution prevented blood
contamination of the syringe [7]. Only if IV extension
tubing is used will the third injection site (furthest from
the patient) remain uncontaminated. The extension tub-
ing itself cannot be used on multiple patients safely, and
one instance of such reuse has already led to a major
patient notification and outbreak investigation in the U.S.
(Broward General Medical Center, Fort Lauderdale, Flor-
ida). The expense of providing each patient with exten-
sion tubing renders the precaution potentially more
expensive than using a new needle and syringe for every
injection. All forms of indirect reuse have been linked to
HBV or HCV transmission in outbreak investigations [8].
Reuse of the syringe after changing the needle has been
linked to rapid HIV transmission in an outbreak investi-
gated in Russia in 1989 [9]. An outbreak of HIV traced to
syringe reuse to flush an IV line at a dialysis clinic in
Egypt in 1993 led to 64 infections in patients, or 32% of
all HIV infections in Egypt at that time [10].
Problems with health governance in public hospitals in
Cameroon also contribute to unsafe practices such as
reuse without sterilization. For example, a healthcare
worker may illegally collect money from a patient to
buy syringes or surgical materials and then economize
on the number of syringes or materials bought, to
maximize personal gain. Health workers earn $400 per
month after taxes, $55 less than the cost of supporting
an average family of five. In addition, most hospital
sharps waste disposal systems are substandard (authors’
personal observation). The presence of loose sharps
waste contributes to reuse of equipment for the same
patient or use of leftovers from another patient. The
community does not participate in deciding how or
where medical waste is disposed, and dumping of sharps
waste in open spaces creates additional risk.
The connection between problems with health govern-
ance and problems with infection control is not unique
to Cameroon. The U.S. Centers for Disease Control
(CDC) has supported investigations that identified unsafe
injections among the important transmission routes in
three large iatrogenic HIV outbreaks in Romania [11-15],
Kazakhstan [16], and Kyrgyzstan [17]. In 2010 the CDC
investigated the exceptionally high prevalence of HIV in
the rural town of Jalal Pur in Pakistan, an anomaly dis-
covered at a mobile HIV screening in 2009. This investi-
gation determined that over many years unsterile medical
injections acted as a bridge between the concentrated
HIV epidemic in high risk groups and the general popu-
lation [18]. All of these outbreaks were traced to corrupt
practices by health workers who either reused equipment
without precautions or practiced extortion by charging
patients for supplies that were not new.
The World Health Organization recommends an
observational assessment protocol (Tool C) for evaluat-
ing medical injection safety in developing countries [19].
An injection safety assessment team observed 92 injec-
tions at 77 health care facilities in Cameroon in 2003
using Tool C. These observers found that 100% of injec-
tions were given with a needle and syringe taken from a
new, sealed package [20]. Indirect reuse was hardly
observed, as 98% of reconstitutions were performed with
a needle and syringe taken from a new, sealed package.
These findings are a seeming underestimate of actual
reuse rates. Observational patient safety performance
assessments are problematic because the presence of a
visiting observer influences performance and adherence
to the standard precautions. This research methods pro-
blem is usually referred to as the Hawthorne effect.
The authors have commonly observed unsafe reuse in
the Northwest Province of Cameroon. Patients who
make an informal payment for a new needle and syringe
may receive an injection with a used syringe. The
Cameroon Ministry of Public Health launched a cam-
paign against hospital corruption in 2007, ‘Hopital Sans
Corruption.’ This campaign attempted to educate
patients not to pay for any medical services directly to
health care workers or without the issuance of hospital
receipts. This campaign was not welcomed by healthcare
workers and it soon died down as they argued that these
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being (authors’ personal observation). An initial study
revealed that the primary consequence of poor govern-
ance at district hospitals was poor quality of service.
Interest in health governance reform is ongoing. The
district health service of Bali requested the assistance of
the Netherlands Development Organization in 2010 to
evaluate the concrete effects of poor governance in
terms of unsafe injection practices.
The purpose of this survey of infection control prac-
tices in maternity wards and outpatient wards in all
public hospitals in two rural health districts was to
assess the risk to patients from injection equipment
reuse. These health districts are located in the North-
west Province of Cameroon, a region noted within the
country for higher standards of patient care. Survey
methods that probe for misconceptions about injection
safety were compared with records indicating how many
syringes and needles are supplied to these hospitals. We
also assessed sharps waste disposal at these hospitals.
The rates of blood-borne virus transmission through
unsafe medical injections in these hospitals were esti-
mated using a model. Data on injection frequency were
taken from the national Demographic and Health Survey
conducted in 2004 [21].
Methods
A total of 69 (of 98) health workers at fifteen hospitals
were interviewed on their own infection control prac-
tices. In assessing injection safety, we investigated four
types of reuse: (1) reuse of the syringe and needle, (2)
reuse of the needle after changing the syringe, (3) reuse
of the syringe after changing the needle, and (4) reuse of
an e e d l eo rs y r i n g et of l u s hap a t i e n t ’s catheter. These
questions (see Additional file 1) were selected to capture
the most common types of reuse identified in blood-
borne virus outbreaks [8]. Data collectors were drawn
from among health staff working at the hospitals investi-
gated who were highly motivated to improve injection
safety. They participated in a six hour workshop in sensi-
tive interviewing techniques. The numbers of needles
and syringes supplied to these hospitals were collected to
investigate whether supplies were inadequate.
The number of HIV, HBV and HCV infections that
result from unsafe medical injections can be estimated
from the number of injections performed (n), the prob-
ability of unsafe reuse (pr), the probability that reused
injection equipment had just been used on an infected
patient (pv), the size of the susceptible population (ps),
and the transmission probability of each virus in an
unsafe medical injection (pt) [22].
Incidence n p p p p rvst =× × × × (1)
The average adult in Cameroon receives 2.4 medical
injections each year according to the 2004 Demographic
and Health Survey (DHS) [21]. The publically available
DHS data set shows that 11.3% of these injections were
given to HIV positive patients. The prevalence of HBV
among blood donors in Cameroon ranges from 6-16%
and the prevalence of HCV in blood donors ranges
from 0.8-3.9% [23,24]. No other recent estimates of
HBV prevalence are available, but these figures may
underestimate population prevalence. Estimates of HCV
prevalence in Cameroon range up to 13.8%, with lower
prevalence in blood donors and young women (1.8-
1.9%) due to a marked age cohort effect [25-28].
The WHO estimates the probability of transmission in
an unsafe medical injection is 1.2% for HIV, 6% for
H B V( b u t3 0 %i ft h es o u r c ep a t i e n ti sac a r r i e ro ft h e
hepatitis B e antigen), and 1.8% for HCV [22]. An esti-
mated 15% of HBV positive adults in Cameroon are car-
riers of the hepatitis B e antigen [29]. The WHO
estimate of the probability of HIV transmission per
unsafe medical injection is the midpoint of a range of
estimates (0.3-2.3%) developed from studies of acciden-
tal needle injuries in health workers [30]. Alternatively,
a nosocomial HIV outbreak infecting more than 1,000
children in Romania suggested transmission rates of
3-7% [30]. Recently it has been argued that rinsing or
wiping injection equipment eliminates this transmission
risk in medical settings [31]. However, a needlestick
accident involves only the insertion of a needle. The
plunger is not depressed in an accidental stick and the
contents of the syringe are not injected. A calculation of
the difference in administered inoculum volume
between insertion of a needle and injection of the con-
tents of the syringe shows that this difference offsets the
reduction in inoculum volume achieved by rinsing a
needle and syringe between uses [32].
Results
In total 44% of health workers reported practicing some
form of unsafe injection equipment reuse. The most
common practice is reuse of the syringe after changing
the needle (36%). Several health workers practiced more
than one type of unsafe reuse. Only 2% of health work-
ers reported they would reuse a needle and syringe on
another patient, but 39% would reuse either the needle
or the syringe. In total 13% would reuse injection equip-
ment to flush a patient’s catheter (Table 1).
Health workers’ self-reported behavior agreed with the
records of injection supplies ordered at some hospitals.
This suggests that many of those who reported reusing
injection equipment did so routinely. Either the overall
syringe reuse rate in the first health district was lower
than the percentage of health workers who reported
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reused syringes when there was no shortage of supply.
Not all hospitals where reuse is practiced had purchas-
ing policies that created a shortage of syringes. (Table 2)
Supply records suggest at least 11% of injections given
in these hospitals were perfo r m e dw i t hr e u s e ds y r i n g e s
in 2009. Under this assumption, unsafe injection prac-
tices may have led to 14-336 HIV infections, 248-661
HBV infections and 7-114 HCV infections between
January and December 2009. Actual numbers may be
higher or lower depending on the injection equipment
reuse practices of other health care providers in these
districts. These estimates are conservative, missing at
least two types of reuse practiced at these hospitals. The
number of unsafe injections administered through intra-
venous lines or with reused needles could not be esti-
mated from the available data.
Only two of the fourteen hospitals used a standard
incinerator for medical sharps waste. All other hospitals
practiced open dumping and irregular burning. Most
burned medical waste more than once a month.
Discussion
In Cameroon, the quest to attain the millennium devel-
opment goals has been greatly hindered, indirectly, by
poor governance issues at public facilities and intract-
able problems with infection control [33]. This survey
revealed that injection equipment reuse is exceedingly
common in Cameroon. Little effort is made to sterilize
syringes between uses on multiple patients. Purchasing
practices have resulted in a shortage of syringes at some
hospitals. This is an unacceptable approach to dealing
with budget shortfalls. Sharps waste management is also
substandard. Self-reported injection equipment reuse
may be more reliable than observational injection safety
assessments, provided the survey instrument probes for
specific types of injection equipment reuse that health
workers may mistakenly believe to be safe. If data col-
lectors are not recruited from among the respondents’
colleagues they cannot reasonably expect to obtain hon-
est answers in a face-to-face interview. Under these cir-
cumstances an anonymous self-administered paper and
pencil questionnaire completed in a one-on-one inter-
view is recommended (see Additional file 1). This
approach has succeeded both in injection safety research
and in research investigating informal payments for
health services [34,35].
Many health staff participating in the survey expressed
a desire to change these unsafe practices. Even those
implicated in corrupt practices were unhappy with the
situation. One respondent in the present survey noted
that he feels nauseous when he ‘eats’ (spends) the money
he collects in illicit payments for unsafe injections. This
remark is consistent with previous research showing that
informal payments for health services are not good for
morale [36]. Nevertheless, informal payments continue to
Table 1 Self-reported injection equipment reuse in
Northwest Province of Cameroon, 2010.
Type of reuse Providers reporting reuse
None 39 (56%)
Syringe and needle 1 (2%)
Syringe only 17 (25%)
Needle only 2 (3%)
Only to flush a catheter 2 (3%)
Syringe or needle 1 (2%)
Syringe/to flush a catheter 7 (10%)
Total 69
Table 2 Supplies of syringes and needles in one health district, January to December 2009.
Hospital Syringes and
needles
Needles Butterfly needles and
canullars
1
Discrepancy between needles and
syringes
2
Self-reported syringe
reuse
Urban public
hospital
2852 700 300 24% 33%
Private hospital 22160 0 405 0% 0%
Rural public
hospital 1
0 100 0 - 0%
Rural public
hospital 2
100 0 50 0% 50%
Rural public
hospital 3
611 0 310 0% 25%
Rural public
hospital 4
927 200 250 21% 25%
District Hospital 3300 2200 2517 67% 66%
Total 29950 3200 3832 11% 36%
1. Used to secure IV lines.
2. (Total needles consumed, excluding butterfly needles and canullars-total syringes consumed) ÷ Total syringes consumed = Total syringes reused, assuming all
needles consumed were used.
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staff in low wage countries where salary payments may
be irregular [37]. Measures to eliminate unsafe injection
equipment reuse must account for the staying power of
these practices. Transparency International ranks the
health sector 9
th among the 20 sectors most affected by
corruption in Cameroon in 2006 [38]. Research into
informal payment systems has shown that improving
wages alone is not an adequate prevention-unless penal-
ties are in force, corrupt practices will continue [39].
Some African countries now restrict the importation of
syringes that do not have reuse prevention features that
engage automatically (see Additional file 2). Additional
file 3 presents a detailed description of corruption pro-
blems in hospitals in Cameroon and proposed measures
to improve health governance.
The practice of reusing injection equipment contri-
butes to millions of serious infections worldwide each
year. The WHO estimates that 5% of HIV infections, 32%
of hepatitis B infections and 40% of hepatitis C infections
result from unsafe medical injections in the developing
world [22]. The high prevalence of hepatitis C virus in
older age groups in Cameroon dates to mass injection
campaigns carried out in the colonial era with unsafe
injection practices [40]. In the effort to eradicate sleeping
sickness, leprosy, and syphilis with intravenous injections,
hepatitis C transmission was so intense that in the most
affected age cohorts prevalence exceeded 50% [41].
Recent research into the viability of HIV recovered from
syringe washes in Cameroon suggests that historic unsafe
reuse of syringes used for phlebotomy and IV injections
and lack of testing of blood for transfusion may have
fueled the massive expansion of HIV subtype CRF_02 in
this region [42]. Ongoing research is exploring the
hypothesis that these practices also contributed to SIV
human infection 50 to 60 years ago.
T h er o l eo fu n s a f em e d i c a li n j e c t i o n si nA f r i c a ’sH I V
epidemic has been debated since the beginning of
H I Ve p i d e m i o l o g y[ 4 3 ] .W h e no n l yd a t ao np r e v a l e n t
HIV infection were available, it made sense to assume
that injections were associated with HIV infection
because those with advanced HIV and AIDS needed
curative injections. Most reports on the association
often observed between receiving medical injections and
recent HIV infection note that this data is also difficult
to interpret. Fourteen prospective studies conducted in
Africa looked at curative and birth control injections as
causes of recent HIV infection [44-57]. The median
fraction of HIV transmission attributed to medical injec-
tions in these studies is 18%. These associations are
often discounted because little was done to control for
overlapping sexual exposures or the need for medical
injections to treat early HIV disease (seroconversion
illness).
More recently, Brewer, Roberts and Potterat have
shown that antenatal tetanus injections and phlebotomy
injections are associated with prevalent HIV infection in
ten countries sub-Saharan Africa, including Cameroon
[58]. This study is well controlled for demographic and
sexual confounders. This analysis excluded women who
had previously tested for HIV and who may have been
referred to antenatal care for screening to enroll in ser-
vices for the prevention of mother-to-child HIV trans-
mission. The combined adjusted odds ratio for exposure
to these two punctures is 1.29 (95% CI 1.08-1.54). As
80% of women who had been pregnant within the past
5 years in Cameroon had been exposed, this risk factor
explains 19% of HIV infections in women with young
children in Cameroon. A possible confounder in this
association between HIV and tetanus and phlebotomy
injections is the receipt of other unsafe injections during
attendance at the antenatal clinic. Some women may
have stopped by for antenatal services because they
were attending the clinic for other curative services.
Like research into HIV origins, controversies in con-
temporary blood-borne HIV epidemiology in Africa are
tied up in a narrative of blame [59]. The practice of
unsafe reuse raises ethical concerns for the public health
community, and the language of injustice has been
invoked to advocate for reform [60]. Health workers are
bound by the Principles of Non-Maleficence and Benefi-
cence to take every possible measure to protect vulner-
able patients from healthcare-associated infections [61].
We are certain that the realm of the possible now
includes the prevention of HIV transmission from
patient to patient in countries with generalized AIDS
epidemics. In 2004, 15 predominately Western authori-
ties in HIV epidemiology wrote to Lancet that the effect
of the elimination of unsafe injections would be incon-
sequential to the AIDS epidemic in Africa [31]. Five
years later, 27 predominately African scientists and pub-
lic health officials signed a joint statement of the
research agenda concerning unsafe health care in Africa
listing several flaws in this argument [62]. They called
for higher quality research into blood-borne HIV and an
end to tolerance for unsafe health care practices.
Resource constraints continue to hinder the fight
against HIV in Africa, and the moral distress this causes
health workers is a strain on the profession [63]. An
ethos of triage has been invoked in the field of HIV
research in the interests of shutting down debate over
blood-borne HIV [31]. A timely interest in pursuing a
zero tolerance policy for nosocomial HIV in high preva-
lence countries is nevertheless possible. Observational
i n j e c t i o ns a f e t ya s s e s s m e n t sa c r o s sA f r i c ah a v es h o w n
widespread endorsement of single use policies [64].
Underlying problems with indirect reuse make health
workers uncomfortable and can certainly be changed.
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targets for reform [65].
Despite single use guidelines in the World Health
Organization’s best practices for safe injections, injection
equipment reuse is common practice where resources for
injection safety training and infection control supervision
are lacking. Indirect reuse, such as reusing a syringe after
changing the needle, has been specifically reported in
B u r k i n aF a s o ,S o u t hA f r i c aa n dS w a z i l a n d[ 6 6 - 6 8 ] .T h e
same practices are still reported by a few injection provi-
ders in high income developed countries, including the
U.S. [69,70] We hypothesize that other forms of indirect
reuse can also be observed around the world. The mis-
conceptions that lead to reuse without sterilization seem
to arise from the structure and appearance of injection
equipment and not from local traditions. We outline
methods for assessing the relative importance of various
specific misconceptions in Additional file 4.
In 2000, syringe reuse rates in Burkina Faso were
comparable to contemporary reuse rates in the United
States. This achievement stands in the face of wide-
spread pessimism about the possibility of eliminating
unsafe reuse in least developed countries. Burkina Faso
has since adopted a national injection safety policy that
restricts the importation of syringes that are not reuse
prevention feature syringes that engage automatically,
like the auto-disable syringe.
In 2001, the World Health Organization recommended
the use of auto-disable syringes for all immunization
injections in the Expanded Programme on Immuniza-
tions. For the first several years of this guideline, this
recommendation did not cover reconstitution syringes.
A more recent recommendation for autodisable syringe
use issued by UNICEF applies to reconstitution syringes
as well. The reconstitution syringe can contaminate a
multi-dose vial if reused on the same patient when draw-
ing more vaccine, and if the contaminated multidose vial
is used again multiple subsequent patients can be
infected. Viable HIV has been recovered from an experi-
mentally contaminated medication vial, showing that an
HIV outbreak may also occur if injection equipment is
reused on the same patient when accessing a multi-dose
vial or saline bag [71]. Multiple viral hepatitis outbreaks
in the U.S. have been traced to this practice [8].
Importantly, the majority of medical injections given
in Africa are not immunization injections. In the Demo-
cratic Republic of Congo, Nigeria, Tanzania and
Uganda, reuse prevention feature syringes are now
required for all medical injections. Like Burkina Faso,
Tanzania now restricts the importation of syringes that
do not have reuse prevention features that engage
automatically.
Another WHO target for improving injection safety in
developing countries is eliminating unnecessary medical
injections. The overuse of injectable medicines in devel-
oping countries is often perceived as demand-driven,
due to cultural beliefs that injections are more powerful
than other forms of medication. But recent research has
s h o w nt h a ti n j e c t i o np r o v i ders overrate demand for
injections and are mistaken to assume that all their
patients wish to receive an injection. Overuse of injec-
tions is also institutionalized in national essential drug
lists. There are 32 injectable drugs (excluding five anes-
thetic agents) on Cameroon’s essential drug list (out of
149 medications). Of these injectable drugs, all but
seven are available in oral formulations. Countries facing
serious problems with injection equipment reuse could
replace injectable drugs with their oral formulations on
the national essential drug list to reduce risk. The tran-
sition to oral first-line treatment for malaria throughout
sub-Saharan Africa has made important inroads in this
direction.
Under the President’s Emergency Plan for AIDS Relief
the U.S. CDC will support and USAID will fund any
iatrogenic HIV outbreak investigation in Africa if invited
to support such an investigation by the Ministry of
Health. However, at present resources for identifying
outbreaks are limited in Africa. Surveillance for HIV
infections in children with HIV negative mothers exists
only in South Africa [72]. CDC officials have indicated
an interest in launching an investigation at the point
when unsafe injection practices are identified rather
than limiting investigations to recognized clusters of epi-
demiologically linked infections [8]. Detection of out-
breaks is difficult even where blood-borne virus
surveillance exists. Routine case-investigations have
shown 50% of persons interviewed do not report beha-
vioral risk factors for acute hepatitis B and C in the U.S.
[73] This finding suggests widespread undetected noso-
comial transmission in a country with blood-borne virus
surveillance and low levels of reuse. Problems in high
prevalence countries may be quite serious without being
obvious in the absence of surveillance.
Unfortunately programmatic funding for injection
safety interventions under PEPFAR ended in 2010. Mil-
lions of dollars have been spent developing and support-
ing national injection safety policies in ten African
countries under PEPFAR’s Making Medical Injections
Safer (MMIS) program. However, these interventions
only indirectly addressed unsafe reuse, by promoting the
standard that a new needle and syringe be removed
from a new, sealed package for every injection for the
patient to see. This standard was developed to empower
patients. In many countries this training was supported
with public education campaigns creating demand for
safe injections. However, this standard does not involve
the patient as an active observer if injections are given
to inpatients through an IV line. Countries that achieved
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also showed less compliance during reconstitution. This
discrepancy may arise from the persistent misconception
that it is safe to reuse on the same patient. Although
MMIS trained thousands of health workers in injection
safety, they did not explicitly address the misconceptions
that lead to indirect reuse.
The efficacy of MMIS interventions carried out so far
has only been assessed using WHO Tool C [64]. Our
findings suggest Tool C is an inconclusive measure of
blood-borne virus transmission risk. Continued attention
to injection safety in MMIS countries and programmatic
interventions in other African countries are still needed.
Advocacy to PEPFAR and other donor programs and
research funding bodies should place due emphasis on
stopping the reuse of syringes, inappropriate use of mul-
tidose vials, and reuse to access IVs. Injection safety
assessments in developing countries that fail to observe
reuse during formal visits should not engender a false
sense of security about the safety of injection practices.
Unsafe reuse is a sensitive behavior that has not yet
been eradicated in the United States [70]. Injection
equipment reuse is a possible threat to public health
that warrants further investigation in most countries
with a high prevalence of blood-borne viruses.
We do not join other authors in calling for a realloca-
tion of research and prevention funds presently needed
in the fight against sexual HIV transmission. We con-
sider the positive evidence of a heterosexual HIV epi-
demic in Africa robust and uncontroversial. Much has
been made of the null results of randomized control
trials studying STD treatment as an HIV prevention
measure [74,75]. Nevertheless, exposure to other STDs
is reliably predictive of exposure to HIV in observational
studies [76]. Randomized treatment trials have no bear-
ing on this research finding. As resources for HIV pre-
vention diminish, injection safety interventions need to
be integrated into other health systems strengthening
and health workforce development programs. They can-
not be expected to compete for priority with sexual HIV
prevention activities.
Conclusions
The present survey, unlike a previous observational
assessment of injection safety in Cameroon using WHO
Tool C, detected high rates of injection equipment reuse
without sterilization. Our approach to probing for
unsafe reuse, a sensitive behavior that may be concealed
from visiting observers, may be more effective than the
WHO standard. Where data collectors cannot be
enrolled from among local health staff and prepared in
an intensive workshop to perform sensitive interviews,
alternative strategies are needed. Anonymous written
questionnaires probing for the common misconceptions
that explain reuse without sterilization have succeeded
in other settings in developing and high income devel-
oped countries.
The autodisable syringe may be an appropriate solu-
tion to injection safety problems in some hospitals in
Cameroon. Corruption contributes to unsafe reuse in
this health care system and may frustrate interventions
that depend on voluntary behavior change. However,
injection safety trainings may also have benefit, as pro-
viders readily admitted to unsafe practices. The Safe
Injections Coalition based in the U.S. has developed
multimedia injection safety training materials that spe-
cifically address the misconceptions that lead to reuse
without sterilization, the “One and Only Campaign”
video, signage and brochures http://www.oneandonly-
campaign.org/. Patients should be taught to expect to
see a new needle and syringe removed from a new,
sealed package for every injection. Educational inter-
ventions in health systems where serious problems
with corruption are directly linked to unsafe practices
should be supported with institutional reforms to
improve health governance. Implementation of these
strategies will take time. A more immediate, adminis-
trative strategy to reduce risk is to replace injectable
drugs with their oral formulations on the national
essential drug list.
Additional material
Additional file 1: A Patient Safety Assessment protocol that lays out
both the procedures piloted in Cameroon and an alternative
formulation for use as an anonymous questionnaire to be self-
administered in a one-on-one interview. These questions performed
well in the field and are recommended to rapidly establish whether a
risk of blood borne virus transmission exists at a given health care facility.
Additional file 2: A policy document from the Tanzania Food and
Drugs Authority. It describes the new injection safety policy in Tanzania,
restricting the importation of syringes that do not have reuse prevention
features that engage automatically.
Additional file 3: Hospital corruption in Cameroon. A copy of a
newsletter that details the findings and recommendations of recent
investigations into hospital corruption in Cameroon.
Additional file 4: Questions for All Injection Providers. An expanded
injection safety assessment questionnaire informed by infection control
compliance research that explores the reasons for unsafe injection
equipment reuse.
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